Full-Time

VP – Corporate Development

Posted on 11/15/2024

Iterative Health

Iterative Health

51-200 employees

AI-driven solutions for gastrointestinal healthcare

AI & Machine Learning
Healthcare

Senior, Expert

Cambridge, MA, USA + 1 more

More locations: New York, NY, USA

Category
Corporate Finance
Finance & Banking
Required Skills
Financial analysis
Requirements
  • Experience in private equity or with the private equity acquisition roll-up model, with a focus on buy-and-build strategies and portfolio company growth, or similar position in healthcare
  • Proven experience in managing end-to-end M&A transactions, particularly within healthcare, with a strong understanding of deal structuring, negotiation, and due diligence
  • Strong negotiation skills with a track record of achieving favorable terms in high-stakes transactions
  • Excellent communication skills, with the ability to manage and influence cross-functional teams and external partners
  • Strategic thinker with strong analytical and problem-solving capabilities
  • Desire to be wear many hats and a willingness to jump on to various projects as needed
  • Deep understanding of the healthcare sector, particularly within clinical trials, site operations, and regulatory considerations
  • Familiarity with clinical trial processes, site management practices, and compliance requirements within the healthcare industry
  • Previous experience with international (non-US) acquisitions, especially in EU
  • MBA or equivalent degree
  • Experience working in a fast growing startup
Responsibilities
  • Drive the company’s acquisition strategy, identifying and securing high-value clinical trial sites and healthcare assets that align with long-term growth goals
  • Utilize deep market expertise and analytical skills to identify acquisition targets with high potential, while remaining responsive to competitive dynamics and industry trends
  • Take ownership of the full transaction lifecycle, from structuring deals and performing due diligence to managing financial analyses and negotiating terms, ensuring optimal deal outcomes
  • Work collaboratively across finance, legal and operational teams to ensure smooth post-acquisition integration, maximizing value and ensuring alignment with overarching strategic goals
  • Develop and deliver compelling acquisition proposals, financial summaries, and performance reports to the executive team and board, ensuring buy-in and alignment with corporate vision
  • Identify, assess, and mitigate potential financial, regulatory, and operational risks associated with acquisitions

Iterative Health focuses on improving gastrointestinal (GI) care through the use of artificial intelligence (AI) and machine learning (ML). Their main product, SKOUT®, is an FDA-cleared device designed to help doctors detect adenomas, which are precursors to colorectal cancer. This device works alongside physician judgment to enhance the accuracy of diagnoses. In addition to SKOUT®, Iterative Health provides services that optimize clinical trials by using AI-enabled documentation technology, which improves patient care and ensures high-quality reporting across different healthcare institutions. This technology aims to make advanced care more accessible, especially to underserved populations. Unlike many competitors, Iterative Health combines AI technology with a strong focus on colorectal cancer prevention and clinical trial efficiency. The company's goal is to deliver top-tier GI care and improve patient outcomes globally.

Company Stage

Series B

Total Funding

$182.1M

Headquarters

Boston, Massachusetts

Founded

2017

Growth & Insights
Headcount

6 month growth

-9%

1 year growth

-18%

2 year growth

-25%
Simplify Jobs

Simplify's Take

What believers are saying

  • The recent $150 million Series B funding round positions Iterative Health for accelerated growth and innovation in AI-driven GI care.
  • Strategic partnerships with major GI groups like Gastro Health and One GI® expand their clinical research capabilities and market reach.
  • Recognition of their leadership, such as Jonathan Ng being named to the PharmaVoice 100, underscores the company's influence and potential in the healthcare sector.

What critics are saying

  • The specialized focus on GI care may limit market opportunities compared to broader healthcare AI applications.
  • Integration challenges from recent acquisitions could disrupt operations and slow down innovation.

What makes Iterative Health unique

  • Iterative Health leverages AI and ML specifically for gastrointestinal care, setting it apart from broader healthcare AI applications.
  • Their FDA-cleared SKOUT® device enhances physician accuracy in detecting adenomas, a unique offering in colorectal cancer prevention.
  • The company's AI-enabled documentation technology standardizes high-quality reporting, making advanced GI care accessible to underserved populations.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Vision/Dental/ Medical Insurance

Life/Disability Insurance

Parental Leave

Stock Options

Flexible Work Hours

Unlimited Paid Time Off